Key facts
- This page summarizes Bo-Xiang Zhang's Form 3 filing for YD Bio Ltd (YDES).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Mar 2026, 16:04.
Bo-Xiang Zhang - 18 Mar 2026 Form 3 Insider Report for YD Bio Ltd (YDES)
- Reporting relationship
- Chief Medical Officer, Director
- Issuer ticker
- YDES
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Bo-Xiang Zhang
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Bo-Xiang Zhang filed Form 3 for YD Bio Ltd (YDES) on 27 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002124891
Primary reporting owner
Zhang Bo-Xiang
- Relationship
- Chief Medical Officer, Director
- Address
- C/O YD BIO LIMITED, 12F., NO. 3, XINGNAN ST., NANGANG DIST., TAIPEI CITY, TAIWAN
- Signature
- /s/ Bo-Xiang Zhang
- Signature date
- 27 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
YDES
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 31,141
- Date
- 18 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24 - Power of Attorney